Two hundred and three adult males were evaluated for the presence of microalbuminuria. Out of 203 patients, 123 (61%) tested negative for microalbuminuria and 80 (39%) tested positive. Patients were further evaluated for age, body mass index, cigarette smoking, blood pressure, serum lipid levels, renal function, cardiovascular events, and use of antihypertensive and antihyperlipidemic medications. This study shows that age greater than 70 years, creatinine clearance less than 50 mL/min, and systolic blood pressure greater than or equal to 140 mm Hg are all significant risk factors for microalbuminuria.
VolpeM., CosentinoF., RuilopeL.Is it time to measure microalbuminuria in hypertension?J Hypertens.2003; 21: 1213–1220.
2.
StuvelingE.M., HillegeH.L., BakkerS.J.L.C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis.2004; 172: 107–114.
3.
RosaT.T., PalatiniP.Clinical value of microalbuminuria in hypertension. J Hypertens.2000; 18: 645–654.
PalatiniP., GranieroG.R., MorminoP.Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the hypertension and ambulatory recording Venetia study (HARVEST Study)Am J Hypertens.1996; 9: 334–341.
10.
NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: National Heart, Lung, and Blood Institute; 1998: 98–4083.
11.
ChobanianA.V., BakrisG.L., BlackH.R.Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension.2003; 42(6): 1206–1252.
12.
National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: part 5: evaluation of laboratory measurements for clinical assessment of kidney disease. Estimation of GFR. Am J Kidney Dis.2002; 39: S76–S110.
13.
Micro-Bumintest Test Kit for Urinalysis Protein (albumin).1997: Bayer Corporation, Elkhart, IN.
14.
KahnH.A., SemposC.T.Statistical Methods in Epidemiology. Monographs in Epidemiology and Biostatistics, Vol 12.Oxford, UK: Oxford University Press; 1998.
15.
SinzingerH., KritzH., FurbergC.D.Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance. Med Sci Monit.2003; 9: 188–192.
16.
NakamuraS., KawanoY., InenagaT.Microalbuminuria and cardiovascular events in elderly hypertensive patients without previous cardiovascular complications. Hypertens Res.2003; 26: 603–606.
17.
BianchiS., BigazziR., CampeseV.M.Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis.1999; 34: 973–995.
18.
KnightE.L., KramerH.M., CurhanG.C.High normal blood pressure and microalbuminuria. Am J Kidney Dis.2003; 41: 588–595.
19.
LeonciniG., ViazziF., ParodiD.Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension.2003; 42: 14–18.
20.
GargJ.P., BakrisG.L.Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med.2002; 7: 35–43.
21.
CampeseV.M., BianchiS., BigazziR.Association between hyperlipidemia and microalbuminuria in essential hypertension. Kidney Int Suppl.1999; 56: S10–S13.
22.
KeaneW.F., MulcahyW.S., KasiskeB.L., KimY., O'DonnellM.P.Hyperlipidemia and progressive renal disease. Kidney Int Suppl.1991; 31: S41–S48.
23.
TonoloG., CiccareseM., BrizziP.Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long term simvastatin treatment. Diabetes Care.1997; 20: 1891–1895.
